期刊文献+

手术治疗肝豆状核变性并脾功能亢进的疗效评价 被引量:6

Evaluation of therapeutic efficacy on hepatolenticular degeneration complicated with hypersplenism by surgical treatment
下载PDF
导出
摘要 目的评价脾切除术联合胃底贲门周围血管离断术治疗肝豆状核变性并脾功能亢进的疗效。方法 148例肝豆状核变性并脾功能亢进患者行脾切除术联合胃底贲门周围血管离断术治疗,检测患者的血常规、肝功能变化,评定手术疗效。结果手术后1周,患者血小板(PLT)、白细胞(WBC)较手术前显著升高(P<0.05),甚至超过正常范围;手术后1月的PLT、WBC水平则显著回落,恢复正常水平。谷丙转氨酶、谷草转氨酶、总胆红素术前处于较高水平,术后1周较术前进一步升高(P<0.05),而术后1月时其水平较术前及术后1周均有显著下降(P<0.05)。结论脾切除术联合胃底贲门周围血管离断术治疗肝豆状核变性并脾亢,对恢复外周血细胞数量、保护肝功能均有显著作用。 Objective To evaluate the therapeutic efficacy of hepatolenticular degeneration complicated with hypersplenism treated by splenectomy combined with disarticulation of cardiac peripheral vessels.Methods A hundred and forty-eight patients with hepatolen-ticular degeneration complicated with hypersplenism treated by splenectomy combined with disarticulation of cardiac peripheral vessels took routine blood and liver function tests to evaluate the surgical treatment.Results One week after surgery,the amount of PLT and WBC significantly increased,higher than before operation (P 〈0.05),even beyond the normal range.One month after surgery,the a-mount of PLT and WBC significantly decreased to normal range.The level of ALT,AST and TBil stay high before operation,even higher 1 week after operation(P 〈0.05),yet it was significantly decreased in 1 month after operation compared with before and 1 week after operation.Conclusions There is significant effect on decreasing the amount of peripheral blood cells and protect the liver function by the treatment of hepatolenticular degeneration complicated with hypersplenism by splenectomy combined with disarticulation of cardiac peripheral vessels.
出处 《安徽医药》 CAS 2015年第1期104-106,共3页 Anhui Medical and Pharmaceutical Journal
关键词 肝豆状核变性 脾功能亢进 脾切除术 胃底贲门周围血管离断术 hepatolenticular degeneration hypersplenism splenectomy gastroesophageal devascularization
  • 相关文献

参考文献9

二级参考文献49

共引文献27

同被引文献78

  • 1罗文颖,陈旭素,郑玉凤,朱琼芳,黄毓婵.麻醉恢复室全麻术后病人低温的护理[J].现代护理,2004,10(11):1036-1037. 被引量:27
  • 2蔡永亮,杨兴涛,杨任民.肝豆状核变性脾切除的探讨——(附42例报告)[J].临床神经病学杂志,1993,6(3):131-133. 被引量:15
  • 3Dunne RM, Shyn PB, Sung JC, et al. Percutaneous treatment of hepatocellular carcinoma in patients with cirrhosis: A comparison of the safety of cryoablation and radiofrequency ablation.. European Journal of Radiology, 2014, 83(4):632-638.
  • 4Liu GJ, Ji Q, Moriyasu F, et al. Value of contrast-enhanced ultrasound using perflubutane microbubbles for diagnosing liver fibrosis and cirrhosis in rats.Ultrasound in Medicine and Biology, 2013, 39(11):2158-2165.
  • 5Yeung LWY, Guruge KS, Taniyasu S, et al. Profiles of perfluoroalkyl substances in the liver and serum of patients With liver cancer and cirrhosis in Australia. Ecotoxicology and Environmental Safety, 2013(96):139-146.
  • 6Gu J J, He XH, Li WT, et al. Safety and efficacy of splenic artery coil embolization for hypersplenism in liver cirrhosis. Acta Radiologica, 2012, 53(8):862-867.
  • 7Terai S, Takami T, Yamamoto N, et al. Status and prospects of liver cirrhosis treatment by using bone marrow-derived ceils and mesenchymal cells. Tissue engineering, Part B. Reviews, 2014, 20(3):206-210.
  • 8Zheng G, Zhang LJ, Zhong J, et al. Cerebral blood flow measured by arterial-spin labeling MRI: A useful biomarker for characterization of minimal hepatic encephalopathy in patients with cirrhosis. European Journal of Radiology, 2013, 82(11):1981-1988.
  • 9于洪量.B超引导下经皮脾穿刺无水乙醇注射治疗脾功能亢进合并门脉高压征的有效性和安全性.医药前沿,2013(4):126-127.
  • 10Rauscher I, Eiber M, Ganter C, et al. Evaluation of Tlp as a potential MR biomarker for liver cirrhosis: Comparison of healthy control subjects and patients with liver cirrhosis. European Journal of Radiology, 2014, 83(6):900-904.

引证文献6

二级引证文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部